MILWAUKEE, June 22, 2026 /PRNewswire/ -- The Medical College of Wisconsin (MCW) today announced a landmark $27 million gift from Tim...
WEST PALM BEACH, Fla., June 22, 2026 /PRNewswire/ -- ImPACT Applications, Inc., the leader in concussion management tools, announced today that...
Columbus, OH, June 19, 2026 (GLOBE NEWSWIRE) -- Nutraville, a natural wellness supplement brand, has launched Pineal Guardian X, a...
Boston company founded by MIT engineers opens reservations for a phone-free sleep system with an AI coach that responds to...
MARYVILLE, Mo., June 17, 2026 /PRNewswire/ -- Mosaic Medical Center - Maryville announced a new partnership with Healium, an immersive media and...
SACRAMENTO, Calif., June 17, 2026 /PRNewswire/ -- Fellow Shareholders,Over the past several months, Lunai Bioworks (NASDAQ: LNAI) has continued to...
SACRAMENTO, Calif., June 17, 2026 /PRNewswire/ -- Fellow Shareholders,Over the past several months, Lunai Bioworks (NASDAQ: LNAI) has continued to...
Interim phase 1/2 data confirm significant anti-fentanyl antibody production at the lowest dose, with a well-tolerated safety profile across all...
New wellness destination combines advanced brain health technology with aesthetic and restorative therapies SPRINGFIELD, Ill., June 16, 2026 /PRNewswire/ -- Blissful...
PHILADELPHIA, June 16, 2026 /PRNewswire/ -- The Pew Charitable Trusts today announced the 2026 class of the Pew Latin American...
Now available directly to patients, MyPhenome is the first and only precision obesity test that goes beyond GLP-1 treatment response...
Now available directly to patients, MyPhenome is the first and only precision obesity test that goes beyond GLP-1 treatment response...
Introduces key products including an integrated brain imaging analysis solution for Alzheimer's disease treatment decision-makingExpands partnering efforts with global pharmaceutical...
Introduces key products including an integrated brain imaging analysis solution for Alzheimer's disease treatment decision-makingExpands partnering efforts with global pharmaceutical...
The new 'virtual biopsy' model predicts brain activity, therapy response, and side effects in patients with up to 3x greater...
Accepted abstracts showcase Nexalin’s proprietary DIFS™ 15 mA 77.5 Hz treatment platform and clinical improvements across anxiety, depression, insomnia and...
With Support from Google.org, Helps Youth and Young Adults to Co-Create Digital Safety Solutions and Advocate for Community WellbeingALTADENA, Calif.,...
The $400,000 prize honors five researchers who developed the first medical device to generate a human sense through a direct...
Harvard neuroscientist tells the D.C. Circuit that expanding marijuana access without fully addressing documented public health risks could have far...
SHELTON, CT / ACCESS Newswire / June 15, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...